 |
|
Phospho(Ser15)/Total HSP27 Whole Cell Lysate Kit
|
| The Phospho(Ser15)/Total HSP27 Whole Cell Lysate Kit provides assay-specific components for the quantitative determination of phospho-HSP27 (Ser15) and total HSP27 in human whole cell lysates. |
|
K15110D-3
|
Phospho(Ser15)/Total HSP27 Whole Cell Lysate Kit |
20 plates |
|
K15110D-2
|
Phospho(Ser15)/Total HSP27 Whole Cell Lysate Kit |
5 plates |
|
Safety, tolerability, pharmacokinetics, and pharmacodynamics of Losmapimod following a single intravenous or oral dose in healthy volunteers.
Barbour AM, Sarov-Blat L, Cai G, Fossler MJ, Sprecher DL, Graggaber J, McGeoch AT, Maison J, Cheriyan J.
|
Br J Clin Pharmacol. |
2012 |
|
ERK activation by GM-CSF reduces effectiveness of p38 inhibitor on inhibiting TNFalpha release.
Hua, F., Henstock, P.V., Tang, B.
|
Int Immunopharmacol. |
2010 |
|
A Randomized, Placebo-Controlled Study of the Effects of the p38 MAPK Inhibitor SB-681323 on Blood Biomarkers of Inflammation in COPD Patients.
Singh, D., Smyth, L., Borrill, Z., Sweeney, L., Tal-Singer, R.
|
J Clin Pharmacol. |
2009 |
|
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.
Angell, R.M., Angell, T.D., Bamborough, P., Bamford, M.J., Chung, C.W., Cockerill, S.G., Flack, S.S., Jones K.L., Laine, D.I., Longstaff, T., Ludbrook, S., Pearson, R., Smith. K.J., Smee, P.A., Somers, D.O., Walker, A.L.
|
Bioorg Med Chem Lett |
2008 |
|
Analysis of mechanistic pathway models in drug discovery: p38 pathway.
Hendriks, B.S, Hua, F., Chabot, J.R.
|
Biotechnol Prog. |
2008 |
|
|
|
|
 |
| Price |
Please call for price |
| Size |
1 plate |
| Catalog No. |
K15110D-1 |
| Availability |
Usually ships in 1-3 days |
|
Home
Products
K15110D-1
